DSpace Collection:http://dspace.bsuedu.ru/handle/123456789/623422026-04-07T13:53:42Z2026-04-07T13:53:42ZAntibiotic resistance of infectious agents associated with prior hospitalizationPerfileva, D. Yu.Miroshnichenko, A. G.Kulikov, E. S.Perfilev, V. Yu.Boykov, V. A.http://dspace.bsuedu.ru/handle/123456789/626692024-05-03T00:10:42Z2024-01-01T00:00:00ZTitle: Antibiotic resistance of infectious agents associated with prior hospitalization
Authors: Perfileva, D. Yu.; Miroshnichenko, A. G.; Kulikov, E. S.; Perfilev, V. Yu.; Boykov, V. A.
Abstract: One of the frequent causes of re-hospitalization is infectious complications due to previous colonization of patient loci by microorganisms circulating in the hospital environment. In the conditions of real clinical practice among hospital-acquired infections (HAI), it is advisable to distinguish a special group of diseases - infections associated with previous hospitalization (IPAH)2024-01-01T00:00:00ZThe effect of dalargin on growth factors content in experimental ulcerative colitisLiashev, A. Yu.Mal, G. S.Solin, A. V.Balanina, M. A.http://dspace.bsuedu.ru/handle/123456789/626672024-05-03T00:14:06Z2024-01-01T00:00:00ZTitle: The effect of dalargin on growth factors content in experimental ulcerative colitis
Authors: Liashev, A. Yu.; Mal, G. S.; Solin, A. V.; Balanina, M. A.
Abstract: The aim of the study was to evaluate the dalargin effect on the content of transforming growth factor-β (TGF-β) and epidermal growth factor (EGF) in the colonic wall in mice with experimental ulcerative colitis2024-01-01T00:00:00ZIdentification and synthesis of metabolites of the new antiglaucoma drugKhokhlov, A. L.Yaichkov, I. I.Korsakov, M. K.Shetnev, A. A.Ivanovskiy, S. A.http://dspace.bsuedu.ru/handle/123456789/626642024-05-03T00:16:09Z2024-01-01T00:00:00ZTitle: Identification and synthesis of metabolites of the new antiglaucoma drug
Authors: Khokhlov, A. L.; Yaichkov, I. I.; Korsakov, M. K.; Shetnev, A. A.; Ivanovskiy, S. A.
Abstract: The determination of biotransformation products is an essential part of the preclinical trial of original medicines. These studies have not been conducted before for the new drug 5-[5- (trifluoromethyl)-1,2-oxazole-3-yl]-furan-2-sulfonamide. Identification and synthesis of metabolite substances are necessary for subsequent tests of bioavailability, linearity of pharmacokinetics, accumulation, distribution and excretion2024-01-01T00:00:00ZEffects of kappa-opioid agonist U-50488 and p38 MAPK inhibitor SB203580 on the spike activity of pyramidal neurons in the basolateral amygdalaKalitin, K. V.Spasov, A. A.Mukha, O. Y.http://dspace.bsuedu.ru/handle/123456789/626622024-05-03T00:09:09Z2024-01-01T00:00:00ZTitle: Effects of kappa-opioid agonist U-50488 and p38 MAPK inhibitor SB203580 on the spike activity of pyramidal neurons in the basolateral amygdala
Authors: Kalitin, K. V.; Spasov, A. A.; Mukha, O. Y.
Abstract: Our study found that the KOR agonist-induced spiking activity of the BLA pyramidal neurons is mediated by the beta-arrestin pathway and can be suppressed by the application of the p38 MAPK inhibitor SB2035802024-01-01T00:00:00Z